Literature DB >> 11289402

Diverse profiles of specific IgE response to toluene diisocyanate (TDI)-human serum albumin conjugate in TDI-induced asthma patients.

H S Park1, H Y Kim, S K Lee, S S Kim, D H Nahm.   

Abstract

The prevalence studies on specific IgE to toluene diisocyanate (TDI)-human serum albumin (HSA) conjugate in TDI-induced asthma have shown variable results. In this study, we attempted to compare specific IgE bindings to TDI-HSA conjugate and its specificity using 3 different conjugates. Sera were collected from 20 TDI-induced asthma and 10 controls. Specific IgE were measured by ELISA using three TDI-HSA conjugates; two from Carnegie Mellon (CM; 98 and 99 CM conjugates) and one from Ajou University. To evaluate specificity and cross-reactivity, ELISA inhibition tests were applied. Positive and negative predictive values between Ajou conjugate and 98 CM conjugate were 75% and 100%. Those between Ajou and 99 CM were 100% and 93.8%. One patient showed an isolated positive response to the Ajou with negative responses to the other two conjugates. ELISA inhibition test using this patient's serum revealed the significant inhibitions by the Ajou and minimal inhibitions by the others. On the other hand, another patient showed an isolated positive response to 99 CM with negative responses to the others, and ELISA inhibition test showed significant inhibition by 99 CM with minimal inhibitions by the others. These results suggest that specific IgE bindings to a new antigenic determinant of TDI-HSA conjugate can be heterogeneous and differ from one individual to another.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289402      PMCID: PMC3054578          DOI: 10.3346/jkms.2001.16.1.57

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  4 in total

Review 1.  Promise and pitfalls in animal-based asthma research: building a better mousetrap.

Authors:  David B Corry; Charles G Irvin
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Biomarkers predicting isocyanate-induced asthma.

Authors:  Nami Shrestha Palikhe; Joo-Hee Kim; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2010-07-29       Impact factor: 5.764

3.  "In Litero" Screening: Retrospective Evaluation of Clinical Evidence to Establish a Reference List of Human Chemical Respiratory Sensitizers.

Authors:  Jessica Ponder; Ramya Rajagopal; Madhuri Singal; Nancy Baker; Grace Patlewicz; Erwin Roggen; Stella Cochrane; Kristie Sullivan
Journal:  Front Toxicol       Date:  2022-07-15

4.  Update on the Pathogenic Mechanisms of Isocyanate-induced Asthma.

Authors:  Gyu-Young Hur; Sung-Jin Choi; Seung-Youp Shin; Sang-Ha Kim; Hae-Sim Park
Journal:  World Allergy Organ J       Date:  2008-01       Impact factor: 4.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.